Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Halpin

Showing results (81-90 of 197) with videos related to

Pageof 20
Sort By:
The European Respiratory Journal|August 15, 2024
Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbationsDavid M G Halpin, Heath Healey, Derek Skinner, et al.
Respiratory Medicine|January 14, 2009
Stratification of COPD patients by previous admission for targeting of preventative careC Bryden, W Bird, H A Titley, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 17, 2006
Patterns of corticosteroid medication use: non-adherence can be effective in milder asthmaColin J Greaves, Michael E Hyland, David M G Halpin, et al.
The Journal of Sports Medicine and Physical Fitness|September 1, 1995
A test to estimate VO2max in females using aerobic dance, heart rate, BMI, and ageM S Olson, H N Williford, D L Blessing, et al.
Respiratory Research|September 25, 2016
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapyDavid M G Halpin, Marjan Kerkhof, Joan B Soriano, et al.
The Lancet. Respiratory Medicine|October 21, 2019
Exercise and pulmonary rehabilitation for people with chronic lung disease in LMICs: challenges and opportunitiesSally J Singh, David M G Halpin, Sundeep Salvi, et al.
Respiratory Medicine|April 26, 2016
Effect of tiotropium on COPD exacerbations: A systematic reviewDavid M G Halpin, Claus Vogelmeier, Michael P Pieper, et al.
Lung|June 17, 2011
Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trialDavid M G Halpin, Marc Decramer, Bartolome Celli, et al.
Eclinicalmedicine|November 12, 2019
Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019David M G Halpin, Hilda J I de Jong, Victoria Carter, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 12, 2012
Exacerbation frequency and course of COPDDavid M G Halpin, Marc Decramer, Bartolome Celli, et al.
Pageof 20

Showing results (81-90 of 197) with videos related to

Sort By:
Pageof 20
The European Respiratory Journal|August 15, 2024
Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbationsDavid M G Halpin, Heath Healey, Derek Skinner, et al.
Respiratory Medicine|January 14, 2009
Stratification of COPD patients by previous admission for targeting of preventative careC Bryden, W Bird, H A Titley, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 17, 2006
Patterns of corticosteroid medication use: non-adherence can be effective in milder asthmaColin J Greaves, Michael E Hyland, David M G Halpin, et al.
The Journal of Sports Medicine and Physical Fitness|September 1, 1995
A test to estimate VO2max in females using aerobic dance, heart rate, BMI, and ageM S Olson, H N Williford, D L Blessing, et al.
Respiratory Research|September 25, 2016
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapyDavid M G Halpin, Marjan Kerkhof, Joan B Soriano, et al.
The Lancet. Respiratory Medicine|October 21, 2019
Exercise and pulmonary rehabilitation for people with chronic lung disease in LMICs: challenges and opportunitiesSally J Singh, David M G Halpin, Sundeep Salvi, et al.
Respiratory Medicine|April 26, 2016
Effect of tiotropium on COPD exacerbations: A systematic reviewDavid M G Halpin, Claus Vogelmeier, Michael P Pieper, et al.
Lung|June 17, 2011
Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trialDavid M G Halpin, Marc Decramer, Bartolome Celli, et al.
Eclinicalmedicine|November 12, 2019
Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019David M G Halpin, Hilda J I de Jong, Victoria Carter, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 12, 2012
Exacerbation frequency and course of COPDDavid M G Halpin, Marc Decramer, Bartolome Celli, et al.
Pageof 20